| scholarly article | Q13442814 |
| P356 | DOI | 10.1117/1.NPH.2.3.031209 |
| P8608 | Fatcat ID | release_ewvu4tvyi5evroeqqtod2j6daq |
| P932 | PMC publication ID | 4729112 |
| P698 | PubMed publication ID | 26839901 |
| P50 | author | Veerle Baekelandt | Q30112409 |
| Wim Vanduffel | Q47494665 | ||
| Zeger Debyser | Q47494689 | ||
| Lieve Moons | Q50923690 | ||
| Marie-Eve Laramée | Q41716294 | ||
| P2093 | author name string | Rik Gijsbers | |
| Lutgarde Arckens | |||
| Samme Vreysen | |||
| Annelies Michiels | |||
| Chris Van den Haute | |||
| Annelies Gerits | |||
| Pascaline Vancraeyenest | |||
| P2860 | cites work | Global and local fMRI signals driven by neurons defined optogenetically by type and wiring | Q22122183 |
| An optogenetic toolbox designed for primates | Q24623252 | ||
| Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry | Q24630976 | ||
| Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain | Q24634574 | ||
| Cyto-, myelo- and chemoarchitecture of the prefrontal cortex of the Cebus monkey | Q28743209 | ||
| Optogenetics in neural systems | Q29618164 | ||
| Parvalbumin neurons and gamma rhythms enhance cortical circuit performance | Q29619163 | ||
| Optical activation of lateral amygdala pyramidal cells instructs associative fear learning | Q30495561 | ||
| Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement | Q30505418 | ||
| Optogenetics in primates: a shining future? | Q30620262 | ||
| Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo | Q30846112 | ||
| An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology | Q33299174 | ||
| Applications of lentiviral vectors for biology and gene therapy of neurological disorders. | Q33392246 | ||
| Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs | Q33536988 | ||
| Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented. | Q33713348 | ||
| Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain | Q33731226 | ||
| Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates | Q33731243 | ||
| Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. | Q34397099 | ||
| Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats | Q34436780 | ||
| AAV hybrid serotypes: improved vectors for gene delivery | Q34619573 | ||
| A high-light sensitivity optical neural silencer: development and application to optogenetic control of non-human primate cortex | Q34853721 | ||
| Remote control of neuronal signaling | Q34858531 | ||
| Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus | Q45743733 | ||
| Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
| Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. | Q45859568 | ||
| Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain | Q45866495 | ||
| Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors | Q45872906 | ||
| Optogenetic dissection of entorhinal-hippocampal functional connectivity | Q46070039 | ||
| Differential effects of monocular deprivation on glutamic acid decarboxylase and type II calcium-calmodulin-dependent protein kinase gene expression in the adult monkey visual cortex. | Q46808132 | ||
| The representation of the visual field in the lateral geniculate nucleus ofMacaca mulatta | Q48455330 | ||
| Genetic dissection of the circuit for hand dexterity in primates. | Q48464398 | ||
| Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain | Q48563498 | ||
| Visual motion processing investigated using contrast agent-enhanced fMRI in awake behaving monkeys. | Q48706578 | ||
| Calcium-binding proteins as markers for subpopulations of GABAergic neurons in monkey striate cortex | Q48926331 | ||
| Controlling the Brain with Light | Q51831377 | ||
| Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors | Q74285552 | ||
| Intravitreal injection of AAV2 transduces macaque inner retina | Q34937075 | ||
| Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain | Q35006292 | ||
| Amygdala circuitry mediating reversible and bidirectional control of anxiety | Q35157906 | ||
| The AAV vector toolkit: poised at the clinical crossroads | Q35876224 | ||
| Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo | Q35948485 | ||
| Integration of adeno-associated virus (AAV) and recombinant AAV vectors | Q35965997 | ||
| Viral vectors as tools to model and treat neurodegenerative disorders | Q36009671 | ||
| Adeno-associated virus (AAV) vectors in the CNS. | Q36173003 | ||
| Saccadic eye movements evoked by optogenetic activation of primate V1. | Q36279307 | ||
| Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. | Q36368045 | ||
| Viral vectors: a wide range of choices and high levels of service | Q36699250 | ||
| Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particles | Q36945745 | ||
| Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation. | Q37171255 | ||
| Transgene expression in target-defined neuron populations mediated by retrograde infection with adeno-associated viral vectors | Q37179765 | ||
| Viral vector-mediated selective and reversible blockade of the pathway for visual orienting in mice | Q37226311 | ||
| Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. | Q37374468 | ||
| Localization of alpha type II calcium calmodulin-dependent protein kinase at glutamatergic but not gamma-aminobutyric acid (GABAergic) synapses in thalamus and cerebral cortex | Q37502868 | ||
| Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). | Q37615161 | ||
| Adeno-associated viral vectors for mapping, monitoring, and manipulating neural circuits | Q37841584 | ||
| A history of optogenetics: the development of tools for controlling brain circuits with light | Q37923765 | ||
| Viral vectors for gene delivery to the central nervous system | Q37946113 | ||
| Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity | Q39686097 | ||
| Grateful DREADDs: engineered receptors reveal how neural circuits regulate behavior. | Q39794154 | ||
| Highly efficient multicistronic lentiviral vectors with peptide 2A sequences | Q39856077 | ||
| CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression | Q40606300 | ||
| Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease | Q40846012 | ||
| Viral vectors, tools for gene transfer in the nervous system | Q40852313 | ||
| Functional organization of thalamocortical relays | Q41187383 | ||
| Cell- and lamina-specific expression and activity-dependent regulation of type II calcium/calmodulin-dependent protein kinase isoforms in monkey visual cortex. | Q41712808 | ||
| Evaluation of the expression pattern of rAAV2/1, 2/5, 2/7, 2/8, and 2/9 serotypes with different promoters in the mouse visual cortex | Q41716240 | ||
| Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectors. | Q41841802 | ||
| Short Promoters in Viral Vectors Drive Selective Expression in Mammalian Inhibitory Neurons, but do not Restrict Activity to Specific Inhibitory Cell-Types | Q41841879 | ||
| Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS mice | Q41900569 | ||
| Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice | Q41918439 | ||
| Axonal transport of adeno-associated viral vectors is serotype-dependent | Q41919978 | ||
| Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex. | Q42186659 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Encoding of conditioned fear in central amygdala inhibitory circuits | Q42822319 | ||
| Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. | Q43109280 | ||
| Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate. | Q43510516 | ||
| Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9. | Q43577652 | ||
| Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system | Q45007196 | ||
| Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters. | Q45264367 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P304 | page(s) | 031209 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Neurophotonics | Q27725607 |
| P1476 | title | Serotype-dependent transduction efficiencies of recombinant adeno-associated viral vectors in monkey neocortex | |
| P478 | volume | 2 |
| Q39151291 | Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates. |
| Q38972892 | Application of viral vectors to the study of neural connectivities and neural circuits in the marmoset brain |
| Q47710128 | Behavioral Manipulation by Optogenetics in the Nonhuman Primate |
| Q33577391 | Comparative study of the transfection efficiency of commonly used viral vectors in rhesus monkey (Macaca mulatta) brains |
| Q56531035 | Focal optogenetic suppression in macaque area MT biases direction discrimination and decision confidence, but only transiently |
| Q39107176 | Gene therapy approaches in the non-human primate model of Parkinson's disease |
| Q97423758 | Histological assessment of optogenetic tools to study fronto-visual and fronto-parietal cortical networks in the rhesus macaque |
| Q47850634 | Nonhuman Primate Optogenetics: Recent Advances and Future Directions. |
| Q39349827 | Optogenetic Modulation of Intracellular Signalling and Transcription: Focus on Neuronal Plasticity |
| Q37127728 | Strategies for targeting primate neural circuits with viral vectors |
| Q90703697 | Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics |
Search more.